Midatech Pharma: MTX110’s Path To Market Fast-Tracked In RGBM
- ByEdison Group-
In a positive development, Midatech (LON:MTPH) (NASDAQ:MTP) has announced the US FDA has granted fast-track designation for its lead clinical asset, MTX110 in recurrent...